UiPath Inc. raised its full-year revenue outlook after cruising past Wall Street’s expectations and swinging to a profit in its latest quarterly results, powered by momentum in its artificial ...
Zacks Investment Research on MSN
UiPath, Inc. (PATH) is attracting investor attention: Here is what you should know
UiPath (PATH) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...
Zacks Investment Research on MSN
UiPath (PATH) is a great momentum stock: Should you buy?
Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long ...
UiPath Inc. shares were on track for their worst daily drop on record after the automation-software company’s latest earnings marked a twist on the industry’s well-established doldrums. Software ...
The company's expenses and the sudden resignation of its CEO are concerning. Yet, UiPath appears to have more going for it than its stock price may indicate. However, the robotics stock may have hit ...
UiPath aims to lead the RPA market by integrating advanced AI solutions, differentiating itself from competitors like Automation Anywhere and Blue Prism. Strategic partnerships with tech giants like ...
We recently published 10 Stocks Sparking Massive Fortunes. UiPath Inc. (NYSE:PATH) is one of the best performers on Friday. UiPath soared 34.7 percent week-on-week to hit a 19-month high, as investors ...
UiPath's stock has dropped ~20% since January, presenting a buying opportunity for long-term investors, despite macroeconomic concerns and disappointing Q4 results. UiPath focuses on agentic ...
UiPath (NYSE:PATH), an international software firm focused on robotic process automation (RPA), experienced a nearly 8% increase in its stock during after-hours trading on Friday and is currently up ...
UiPath launches AI-based Medical Record Summarization tool, reducing processing time from 45 minutes to minutes. Powered by Google Cloud, the agent improves accuracy, saves 40 minutes per referral, ...
Despite my piece lambasting AI agent (over)hype, I am not anti-agent, even if "agentic" is low on my list of favorite buzzwords. I'm just pushing for more precision on the pros and cons - and use case ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback